Literature DB >> 9323015

Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats.

X P Yang1, Y H Liu, G M Scicli, C R Webb, O A Carretero.   

Abstract

Kinins acting on the B2 receptor appear to be involved in the cardioprotective effect of preconditioning on myocardial ischemia/reperfusion injury. We tested the hypothesis that in mice lacking the gene encoding for the B2 kinin receptor (B2 knockout mice; B2-KO) as well as in rats deficient in high-molecular-weight (HMW) kininogen (Brown Norway Katholiek rats; BNK), the cardioprotective effect of preconditioning is diminished or abolished. 129SvEvTac (SV129) mice and Brown Norway rats (BN) served as controls. We confirmed that plasma HMW kininogen in BNK rats was 100-fold lower than in BN and 140-fold lower than in Sprague-Dawley rats (33+/-4 versus 1814+/-253 and 2397+/-302 ng/mL, P<.01). Each strain of mice was divided into (1) controls (without preconditioning); (2) one cycle of preconditioning (3 minutes ligation and 5 minutes reperfusion); and (3) three cycles of preconditioning. Each strain of rats was divided into (1) controls; and (2) three cycles of preconditioning. All animals were subjected to 30 minutes of ischemia and 120 minutes of reperfusion. In SV129 controls, the ratio of infarct size to risk area (IS/AR) was 55.6+/-4.6%. One and three cycles of preconditioning reduced IS/AR to 38.6+/-3.2% and 31.1+/-2.3%, respectively (P<.05 and P<.01 versus control). This protective effect was absent in B2-KO mice: IS/AR was 54.8+/-2.9% in controls, 58.5+/-3.6% with one cycle of preconditioning, and 58.5+/-3.4% with three cycles. In BN rats without preconditioning, IS/AR was 84.7+/-3.9%; preconditioning reduced it to 61.6+/-3.4% (P<.01). In BNK rats, IS/AR was 87.1+/-4.8% in controls and 84.3+/-4.1% with preconditioning. Preconditioning also prevented reperfusion arrhythmias in BN but not BNK rats. Within species, risk area, mean blood pressure, and heart rate were similar between strains. We concluded that (1) preconditioning protects the heart against ischemia/reperfusion injury in mice and rats; (2) activation of prekallikrein, which in turn generates kinins from HMW kininogen, may contribute to the effect of preconditioning; and (3) an intact kallikrein-kinin system is necessary for the cardioprotective effect of preconditioning.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323015     DOI: 10.1161/01.hyp.30.3.735

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

Authors:  G F Baxter; Z Ebrahim
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Modulation of cardiac vagal tone by bradykinin acting on nucleus ambiguus.

Authors:  Eugen Brailoiu; Matthew McGuire; Shadaria A Shuler; Elena Deliu; Jeffrey L Barr; Mary E Abood; G Cristina Brailoiu
Journal:  Neuroscience       Date:  2017-09-23       Impact factor: 3.590

3.  Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction.

Authors:  Jiang Xu; Oscar A Carretero; Ying Sun; Edward G Shesely; Nour-Eddine Rhaleb; Yun-He Liu; Tang-Dong Liao; James J Yang; Michael Bader; Xiao-Ping Yang
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

4.  Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia.

Authors:  Erij Messadi; Marie-Pascale Vincent; Violaine Griol-Charhbili; Chantal Mandet; Juliana Colucci; John H Krege; Patrick Bruneval; Nadine Bouby; Oliver Smithies; François Alhenc-Gelas; Christine Richer
Journal:  FASEB J       Date:  2010-07-28       Impact factor: 5.191

5.  Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice.

Authors:  Lei Xi; Anindita Das; Zhi-Qing Zhao; Vanessa F Merino; Michael Bader; Rakesh C Kukreja
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

6.  Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation.

Authors:  Julie Chao; Hang Yin; Lin Gao; Makoto Hagiwara; Bo Shen; Zhi-Rong Yang; Lee Chao
Journal:  Hypertension       Date:  2008-09-02       Impact factor: 10.190

Review 7.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 8.  Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors.

Authors:  F Kuhr; J Lowry; Y Zhang; V Brovkovych; R A Skidgel
Journal:  Neuropeptides       Date:  2010-01-04       Impact factor: 3.286

9.  Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats.

Authors:  Hiroshi Ito; Izumi Hayashi; Tohru Izumi; Masataka Majima
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

10.  Bradykinin type-2 receptor expression correlates with age and is subjected to transcriptional regulation.

Authors:  Inka Liesmaa; Naotaka Shiota; Jorma O Kokkonen; Petri T Kovanen; Ken A Lindstedt
Journal:  Int J Vasc Med       Date:  2011-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.